Cargando…
Clinical impact of PTEN methylation status as a prognostic marker for breast cancer
BACKGROUND: Aberrant DNA methylation of phosphatase and tensin homolog (PTEN) gene has been found in many cancers. The object of this study was to evaluate the clinical impact of PTEN methylation as a prognostic marker in breast cancer. The study includes 153 newly diagnosed females, and they were d...
Autores principales: | Ramadan, Amal, Hashim, Maha, Abouzid, Amr, Swellam, Menha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110663/ https://www.ncbi.nlm.nih.gov/pubmed/33970384 http://dx.doi.org/10.1186/s43141-021-00169-4 |
Ejemplares similares
-
Alterations of PTEN and SMAD4 methylation in diagnosis of breast cancer: implications of methyl II PCR assay
por: Swellam, Menha, et al.
Publicado: (2021) -
Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM)
por: Amer, Rehab G., et al.
Publicado: (2022) -
Emerging Role of Endothelial and Inflammatory Markers in Preeclampsia
por: Swellam, Menha, et al.
Publicado: (2009) -
Impact of circulating miRNA-373 on breast cancer diagnosis through targeting VEGF and cyclin D1 genes
por: Bakr, Noha M., et al.
Publicado: (2021) -
Prognostic impact of MYD88 and TP53 mutations in diffuse large B Cell lymphoma
por: Ebid, Osama Abd El Hameed, et al.
Publicado: (2023)